The Biosimilars Conference at the University of Washington

designed for Professionals in the Pharmaceutical and Biotech Industries

March 19-20, 2010
University of Washington

Conference Director

Thomas K. Hazlet, Pharm.D., Dr.P.H.
Associate Professor & Director of Master of Science in Biomedical Regulatory Affairs
School of Pharmacy
University of Washington
Seattle WA

Presenters

Rafael Alfonso, MD, MSc
Research Associate, School of Pharmacy
Pharmaceutical Outcomes Research & Policy Program
University of Washington
Seattle, WA

Thomas A Baillie
Dean, School of Pharmacy
University of Washington
Seattle, WA

Lauret Ballsun, RN, BSN
LBC Pharmaceutical Professionals, LLC

Brian W. Bresnahan, PhD
Research Assistant Professor, Radiology
Adjunct Research Assistant Professor
Pharmaceutical Outcomes Research & Policy Program
School of Pharmacy
University of Washington
Seattle, WA

Carlos Enrique Catalano, Pharm.D., Ph.D.
Professor, Department of Medicinal Chemistry
School of Pharmacy
University of Washington
Seattle, WA

Andrew Fox
Director of Regulatory Affairs
Amgen, Inc.
Thousand Oaks, CA

David Goodlett, MS, PhD
Professor, Department of Medicinal Chemistry
School of Pharmacy
University of Washington
Seattle WA

Royce Morrison, MD, CPI
Director of Clinical Strategy
Charles River Clinical Services Northwest

Sean O'Connor
Associate Professor, School of Law
Co-Director, Graduate Program in IP Law & Policy
Faculty Director, Entrepreneurial Law Clinic
Of Counsel, Seed IP Law Group
www.SeedIP.com
University of Washington
Seattle, WA

Janet Rose Rea, MSPH, RAC
Vice President, Regulatory Affairs and Quality
Poniard Pharmaceuticals
Seattle, WA

Kyle Ross, PhD
UW-Lilly Senior Post-Doctoral Research Fellow
Pharmaceutical Outcomes Research and Policy Program
University of Washington

Kirsten L. Vadheim, Ph.D., RAC
BioCompliance Consulting, Inc.
7710 196th Ave N.E.
Redmond WA 9805

Samuel E. Webb
Partner
Stoel Rives LLP, Seattle